Genentech to Present Pivotal Data at ESMO 2026, Showcasing Advances Across Its Lung and Breast Cancer Late-Stage Portfolio

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. COF
10. GOOGL

Go back to Genentech to Present Pivotal Data at ESMO 2026, Showcasing Advances Across Its Lung and Breast Cancer Late-Stage Portfolio

Roche Q3 preview: UBS says 'FX impact turning to a tailwind'

October 21, 2026 6:00 PM EDT

UBS expects limited new strategic news from Roche (OTC: RHHBY) when the Swiss drugmaker reports third-quarter sales on Thursday.

In a preview note, the bank pointed instead to currency effects, key franchises, and competitor readouts as the main focus areas.

Following the recent Pharma Capital Markets Day, we expect limited new news on the strategic positioning of new launches... More